Thermo Fisher Scientific

• NCT00982111

  Collaborator, Phase 3, Completed, 633 people, 22 Sept 2009

• MGUS in Black individuals in Soweto, South Africa screened by mass spectrometry: results of the PROMISE South Africa study

  Shares or equity, Patents or royalties, 2 Oct 2026

• Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial

  Employment, 17 Sept 2026

• Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model

  Grants or research support, 28 Aug 2026

• Human brain organoids record the passage of time over multiple years

  Consulting or advice, Board or leadership role, 19 Aug 2026

• The telomeric DNA damage response as a therapeutic target in idiopathic pulmonary fibrosis

  Employment, 12 Aug 2026

• Screen-Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long-Term Outcomes and Mortality

  Fees or honoraria, 10 Aug 2026

• Aging-linked systemic lipid signature is reprogrammed by caloric restriction in rhesus monkeys

  Consulting or advice, 10 Dec 2025

• Tissue and cellular spatiotemporal dynamics in colon aging

  Consulting or advice, Board or leadership role, 22 Oct 2025

• Age-related changes of the gastrointestinal tract

  Fees or honoraria, 8 Oct 2025

• Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human

  Consulting or advice, Grants or research support, 17 Apr 2024

• A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories

  Consulting or advice, Board or leadership role, 8 May 2023

• Heterochronic parabiosis reprograms the mouse brain transcriptome by shifting aging signatures in multiple cell types

  Consulting or advice, 9 Mar 2023

Sources: pubmed.ncbi.nlm.nih.gov

• Development of a Model for Predicting Chronological Age Based on DNA Methylation Data from Buccal Swabs Using Ion Torrent S5 Technology

  International journal of molecular sciences, 13 Aug 2026

• Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026